SCHEMBL7464187

SCHEMBL7464187

CCCn1cnc2c1c(=O)[nH]c(=O)n2C1CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 5/20 0.65
ADORA2A P29274 5/20 0.65
PDE4B Q07343 5/20 0.65
PDE4C Q08493 5/20 0.65
PDE4D Q08499 5/20 0.65
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
ALDH1A1 P00352 1/20 0.55
BRD4 O60885 3/20 0.51
BRD2 P25440 2/20 0.51
BRD3 Q15059 2/20 0.51
BRDT Q58F21 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
MAPK1 P28482 2/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
ADORA2B P29275 1/20 0.43
CYP3A4 P08684 1/20 0.41
PMP22 Q01453 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9842833 0.92 ALDH1A1 (0.67) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL9842911 0.91 MEN1 (0.62) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL9842882 0.90 MEN1 (0.60) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL9842568 0.89 PDE4A (0.59) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL9842775 0.85 SMN1; SMN2 (0.47) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL9842711 0.83 MEN1 (0.49) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL9842637 0.82 MAPK1 (0.52) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL9615238 0.82 SMN1; SMN2 (0.44) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL9842532 0.82 CYP3A4 (0.62) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL1495090 0.80 PDE4A (0.76) PDE4AADORA2APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0771813-B1 Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines HOECHST AG (DE) 2002-01-16 EP disclosed
US-5728686-A TREATMENT OF MUSCULAR DYSTROPHY HOECHST AKTIENGESELLSCHAFT (DE) 1998-03-17 US disclosed
EP-0771813-A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1997-05-07 EP disclosed
EP-0430025-A2 Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same HOKURIKU PHARMACEUTICAL CO., LTD. (JP) 1991-06-05 EP disclosed